Celltrion's COVID-19 treatment substance shows efficacy
SEOUL, Sept. 11 (Yonhap) -- Celltrion Inc., a leading pharmaceutical firm in South Korea, said Friday that its coronavirus antibody treatment substance has shown treatment efficacy in clinical trials.
CT-P59 has been administered to 32 healthy volunteers who have not contracted COVID-19 since July after receiving approval for phase one trials from the Ministry of Food and Drug Safety.
It marked the first time that a locally made genetic recombination antibody treatment material was given the green light to be used on people.
This undated image, provided by Celltrion Inc., shows the company's corporate logo. (PHOTO NOT FOR SALE) (Yonhap)
The pharmaceutical company said it will conduct second and third phase clinical trials afterward.
The ministry, which is pushing hard to have a locally made treatment drug, earlier said if all goes well, Celltrion could start mass producing the drug in the first half of 2021. The initial output could be for 5 million people.
Besides local testing, Celltrion also received approvals in seven countries, including Britain, to conduct clinical trials for its material.
khj@yna.co.kr
(END)
-
(URGENT) S. Korea's science minister confirms space rocket Nuri's launch success -
Three indicted in massive stock manipulation case -
(3rd LD) Passenger opens door of Asiana Airlines plane before landing at Daegu airport -
BTS' J-Hope completes basic training for military service -
(6th LD) S. Korea successfully launches space rocket Nuri in major milestone for space program
-
N. Korea's aircraft maintenance activity at 'unusual' level: 38 North -
(LEAD) Asiana Airlines plane's door opens right before landing at Daegu Airport -
(2nd LD) S. Korean experts begin on-site inspection of Fukushima nuclear plant -
(3rd LD) S. Korea delays launch of space rocket Nuri over technical glitch -
Key political figures gather at memorial service of late President Roh
-
U.S. military stages 'Elephant Walk' training with F-16 fighters -
(LEAD) Japanese warship arrives in S. Korea for multinational WMD-interception naval drill -
N. Korea notifies Japan of plan to launch satellite between May 31-June 11: Kyodo -
S. Korea slams N. Korea's planned satellite launch, warns of consequences -
(LEAD) N. Korea notifies Japan of plan to launch satellite between May 31-June 11: Kyodo
